What’s Inside the Q&A:

Launch Path Decision

Explore how biopharma leaders weigh the pros and cons of launching independently versus partnering in Europe.

Investment vs. Return

Understand what shapes the financial calculus behind building a European presence or sharing the load.

Market Fit Factors

See which product and pipeline traits make a self-launch realistic—or why a partner might add more value.

Strategic Evolution

Discover how hybrid and staged models let companies balance control, speed, and long-term ambition.